Jewellery approach rather than industrial scale production
The rouble devaluation has exacerbated the problem of underutilization of pharmaceutical plants, which has emerged in Russia in recent years. New production plants began to pop up like mushrooms in the 2000s. Business people became especially active after the Pharma 2020 Programme was launched. They clearly understood the signals – the pharmaceutical market was growing at a rate of at least 10% annually, and the government intended to support this industry, and the currency fluctuations in 2008-2009 had shown how the pharmaceutical business was resistant to an economic crisis. And everything would have been good, were it not for two "buts". First, the devaluation of five years before was just a mere drill. Second, too many pharmaceutical plants had sprung up, and many of them started going idle.
